Paradigm Biopharmaceuticals Ltd Total Liabilities

Latest as of December 2025: AU$17.16 Million AUD ≈ $12.14 Million USD

Paradigm Biopharmaceuticals Ltd total liabilities. Based on the latest financial reports, Paradigm Biopharmaceuticals Ltd (PAR) has total liabilities worth AU$17.16 Million AUD (≈ $12.14 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Paradigm Biopharmaceuticals Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Paradigm Biopharmaceuticals Ltd (2014–2025)

Total liabilities of Paradigm Biopharmaceuticals Ltd from 2014 to 2025. This chart illustrates how Paradigm Biopharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore PAR long-term investment intensity to see how much of total assets are deployed in long-term investments.

Paradigm Biopharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Paradigm Biopharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Star Holdings NASDAQ:STHO	USA	$304.33 Million
Aifeex Nexus Acquisition Corporation NASDAQ:AIFE	USA	$1.17 Million
Sambo Corrugated Board Co. Ltd KQ:023600	Korea	₩195.44 Billion
Net Insight AB (publ) ST:NETI-B	Sweden	Skr196.14 Million
The Platform Group AG XETRA:TPG	Germany	€180.25 Million
Brii Biosciences Limited F:7SS	Germany	€36.20 Million
Softstar Entertainment TWO:6111	Taiwan	NT$21.04 Billion
Red Star Macalline Group Corporation Ltd F:3S5	Germany	€68.62 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Paradigm Biopharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Paradigm Biopharmaceuticals Ltd.

Liquidity & Leverage Metrics

Paradigm Biopharmaceuticals Ltd Total Liabilities Ratios Explained

Paradigm Biopharmaceuticals Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.31	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.86	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.74	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Paradigm Biopharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Paradigm Biopharmaceuticals Ltd (2014–2025)

The table below shows the annual total liabilities of Paradigm Biopharmaceuticals Ltd from 2014 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$3.39 Million ≈ $2.40 Million	-5.49%
2024-06-30	AU$3.58 Million ≈ $2.54 Million	-73.23%
2023-06-30	AU$13.39 Million ≈ $9.48 Million	+59.88%
2022-06-30	AU$8.38 Million ≈ $5.93 Million	+28.49%
2021-06-30	AU$6.52 Million ≈ $4.61 Million	+55.88%
2020-06-30	AU$4.18 Million ≈ $2.96 Million	+54.62%
2019-06-30	AU$2.70 Million ≈ $1.91 Million	+103.80%
2018-06-30	AU$1.33 Million ≈ $939.01K	+38.92%
2017-06-30	AU$955.29K ≈ $675.93K	-14.45%
2016-06-30	AU$1.12 Million ≈ $790.13K	+93.42%
2015-06-30	AU$577.33K ≈ $408.49K	+56.60%
2014-06-30	AU$368.67K ≈ $260.85K	--

About Paradigm Biopharmaceuticals Ltd

AU:PAR Australia Biotechnology

Market Cap

$91.09 Million

AU$128.74 Million AUD

Market Cap Rank

#19321 Global

#619 in Australia

Share Price

AU$0.25

Change (1 day)

+0.00%

52-Week Range

AU$0.14 - AU$0.39

All Time High

AU$4.35